Miyata R, Hamaji M, Kawaguchi A, Shimazu Y, et al. Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR-mutated lung adenocarcinoma: a multi-institutional retrospective study. Eur J Cardiothorac Surg 2022;62.
PMID: 35997576